Yes / Background: The place of opioids in the management of chronic, non-cancer pain is limited. Even so their use is
escalating, leading to concerns that patients are prescribed strong opioids inappropriately and alternatives to
medication are under-used. We aimed to understand the processes which bring about and perpetuate long-term
prescribing of opioids for chronic, non-cancer pain.
Methods: We held semi-structured interviews with patients and focus groups with general practitioners (GPs).
Participants included 23 patients currently prescribed long-term opioids and 15 GPs from Leeds and Bradford,
United Kingdom (UK). We used a grounded approach to the analysis of transcripts.
Results: Patients are driven by the needs for pain relief, explanation, and improvement or maintenance of quality
of life. GPs’ responses are shaped by how UK general practice is organised, available therapeutic choices and their
expertise in managing chronic pain, especially when facing diagnostic uncertainty or when their own approach is
at odds with the patient’s wishes. Four features of the resulting transaction between patients and doctors influence
prescribing: lack of clarity of strategy, including the risk of any plans being subverted by urgent demands; lack of
certainty about locus of control in decision-making, especially in relation to prescribing; continuity in the doctor-patient
relationship; and mutuality and trust.
Conclusions: Problematic prescribing occurs when patients experience repeated consultations that do not meet their
needs and GPs feel unable to negotiate alternative approaches to treatment. Therapeutic short-termism is perpetuated
by inconsistent clinical encounters and the absence of mutually-agreed formulations of underlying problems and plans
of action. Apart from commissioning improved access to appropriate specialist services, general practices should also
consider how they manage problematic opioid prescribing and be prepared to set boundaries with patients. / National Institute for Health Research (NIHR) under its Research for Patient Benefit Programme (Grant Reference Number PB-PG- 1010–23041).
| Identifer | oai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/17517 |
| Date | 12 November 2019 |
| Source Sets | Bradford Scholars |
| Language | English |
| Detected Language | English |
| Type | Article, Published version |
| Rights | © 2015 McCrorie et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated., CC-BY |
Page generated in 0.002 seconds